Clinical Trials Directory

Trials / Completed

CompletedNCT00235183

Plasma Transfusion in Liver Transplantation

Plasma Transfusion in Liver Transplantation : a Randomized, Double Blind, Multicenter Trial of Methylene Blue, Solvent/Detergent and Quarantined Plasma.

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
300 (estimated)
Sponsor
Etablissement Français du Sang · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The aim of the study is to compare the clinical efficacy of three types of plasma secured on the viral level either by quarantine or by chemical treatment in patients undergoing liver transplantation.

Detailed description

Three types of plasma are transfused in bleeding patients undergoing liver transplantation: * quarantined plasma, * methylene blue treated plasma, * solvent/detergent plasma. The main purpose is to show that the volume of methylene blue treated plasma consumed intraoperatively is equivalent to that of the 2 other types of plasma. In addition, the correction of coagulation abnormalities are studied.

Conditions

Interventions

TypeNameDescription
OTHERplasmatransfusion of more than 15 mL/Kg of plasma

Timeline

Start date
2005-06-01
Primary completion
2009-12-01
Completion
2010-12-01
First posted
2005-10-10
Last updated
2014-02-17

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT00235183. Inclusion in this directory is not an endorsement.

Plasma Transfusion in Liver Transplantation (NCT00235183) · Clinical Trials Directory